ÂÜÀòÂÒÂ×

14 years experience in clinical research at Novartis and ICON (global CRO) including 10 years of managing international clinical studies. Most recent prior role was managing a global Phase III clinical study of >7,000 patients across 43 countries for a cardiovascular drug.